Literature DB >> 16279277

Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project.

Stephen R Wisniewski1, Heather Eng, Leslie Meloro, Robert Gatt, Louise Ritz, Diane Stegman, Madhukar Trivedi, Melanie M Biggs, Edward Friedman, Kathy Shores-Wilson, Diane Warden, Douglas Bartolowits, Jeffrey P Martin, A John Rush.   

Abstract

While efficient methods of communication are known to be essential in conducting large multicenter clinical trials, very little information is provided on actual methods that can be implemented to improve communication. An integrated technology-based communication system was developed for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project, which prospectively defines treatments that are most effective for participants with a diagnosis of a nonpsychotic major depressive disorder (MDD) who report an unsatisfactory clinical outcome to an initial and, if necessary, subsequent treatment(s). This web-based communication system is comprised of a multi-faceted study Web site, including a help desk, document sharing, a project directory and reports. In addition, automated reporting via e-mail and an online data correction mechanism are also available. The STAR*D communication system improves communication between study personnel and improves the quality of the study's data through the integration of system elements, the integration of those elements with traditional forms of communication,, by filling the gaps not addressed by those traditional methods and by reducing the staff workload burden.

Entities:  

Mesh:

Year:  2004        PMID: 16279277     DOI: 10.1191/1740774504cn035oa

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  16 in total

1.  Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.

Authors:  Edward S Friedman; Lori L Davis; Sidney Zisook; Stephen R Wisniewski; Madhukar H Trivedi; Maurizio Fava; A John Rush
Journal:  Eur Neuropsychopharmacol       Date:  2011-09-14       Impact factor: 4.600

2.  Depression treatment in patients with general medical conditions: results from the CO-MED trial.

Authors:  David W Morris; Nitin Budhwar; Mustafa Husain; Stephen R Wisniewski; Benji T Kurian; James F Luther; Kevin Kerber; A John Rush; Madhukar H Trivedi
Journal:  Ann Fam Med       Date:  2012 Jan-Feb       Impact factor: 5.166

3.  Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.

Authors:  Sharon C Sung; Stephen R Wisniewski; James F Luther; Madhukar H Trivedi; A John Rush
Journal:  J Affect Disord       Date:  2014-11-22       Impact factor: 4.839

4.  Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC).

Authors:  Joan E Hilner; Letitia H Perdue; Elizabeth G Sides; June J Pierce; Ana M Wägner; Alan Aldrich; Amanda Loth; Lotte Albret; Lynne E Wagenknecht; Concepcion Nierras; Beena Akolkar
Journal:  Clin Trials       Date:  2010-07-05       Impact factor: 2.486

5.  Quality control of phenotypic forms data in the Type 1 Diabetes Genetics Consortium.

Authors:  Letitia H Perdue; Lotte Albret; Alan Aldrich; Amanda Loth; Elizabeth G Sides; Angela Dove; Ana M Wägner; Rebecca Waterman; June J Pierce; Beena Akolkar; Michael W Steffes; Joan E Hilner
Journal:  Clin Trials       Date:  2010-07-05       Impact factor: 2.486

6.  The clinical relevance of self-reported premenstrual worsening of depressive symptoms in the management of depressed outpatients: a STAR*D report.

Authors:  Charlotte L Haley; Sharon C Sung; A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; James F Luther; Susan G Kornstein
Journal:  J Womens Health (Larchmt)       Date:  2013-03       Impact factor: 2.681

7.  Automated summaries of serious adverse events in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Authors:  Margaret C Bell; Patricia R Robuck; Elizabeth C Wright; Marina S Mihova; Charlotte Hofmann; Jennifer L De Santo; Susan L Milstein; Pamela A Richtmyer; Janel L Shelton; Maureen Cormier; Debra L King; Choon J Park; Wallis A Molchen; Yoon Park; Michelle Kelley
Journal:  Clin Trials       Date:  2009-11-04       Impact factor: 2.486

8.  Web-based data management for a phase II clinical trial in ALS.

Authors:  Richard Buchsbaum; Petra Kaufmann; Alexandra I Barsdorf; Rachel Arbing; Jacqueline Montes; John L P Thompson
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

9.  What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

Authors:  Diane Warden; A John Rush; Stephen R Wisniewski; Ira M Lesser; Susan G Kornstein; G K Balasubramani; Michael E Thase; Sheldon H Preskorn; Andrew A Nierenberg; Elizabeth A Young; Kathy Shores-Wilson; Madhukar H Trivedi
Journal:  Int J Neuropsychopharmacol       Date:  2008-07-09       Impact factor: 5.176

10.  Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.

Authors:  Susan G Kornstein; Marisa Toups; A John Rush; Stephen R Wisniewski; Michael E Thase; James Luther; Diane Warden; Maurizio Fava; Madhukar H Trivedi
Journal:  J Womens Health (Larchmt)       Date:  2013-02       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.